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The idea behind this thesis stems from the existing abundance of empirical studies suggesting the 
strong correlation between longevity and economic growth. In a simple two period overlapping-
generation framework, we establish a direct link between health investment and economic 
growth through endogenous survival rate. We find that health expenditure complements saving in 
equilibrium, thereby contributes to economic growth, which in turn leads to a further increase in 
health investment. The simulation with calibrated parameters also manifests the consistence 
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1. Introduction 
 
The strong correlations between various measures of health and income per capital have 
led macro-economists to regard health as an essential part of any measure of well-being, 
although better health and longer life expectancy are mostly viewed as by-products of 
economic growth and development of a country
1. The causal relationship between 
mortality and poverty is clearly bi-directional. On the one hand, people die young in poor 
country because they can’t afford sanitation and medical care. On the other hand, they 
have less incentive to save if they expect themselves to die young and the economy fails 
to grow. By contrast, micro-economists have carefully looked at the determinants of the 
demand for health and established a bilateral mechanism between health and income: 
Health is analogous to a normal good, and higher income leads to an increase in the 
demand for health, but individual’s health status also affects his or her income and 
earnings through different channels (Grossman 1972). These important results force 
economists to reconsider their analysis of the relationship between economic growth, 
health and longevity in the light of macroeconomic growth models that integrate the 
micro-foundations of health economics. 
 
The present paper follows this goal and modifies the standard two-period overlapping-
generation model developed by Diamond (1965) by incorporating an endogenous health 
investment. Since agents are alive only for a fraction in the second period of their life, 
they may optimally “control” this survival risk by incurring personal expenses on health. 
Agents face the following dilemma: longevity is desirable and necessary to enjoy the 
returns from past physical investments, but longer life is costly to acquire, which leads to 
lower physical investment and hence to a loss in future utility. For comparison, we use a 
benchmark model with an exogenous survival probability. Our main findings are as 
follows. Health investments are complementary to individual savings in equilibrium, 
which means agents will optimally choose to increase or decrease the savings and health 
                                                 
1 Life expectancy is included in the Human Development Index. 
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investment at the same time. In equilibrium, health investment is a normal good which 
increases as income rises. Moreover, our findings are further supported by simulation 
with China’s calibrated parameters. The results are consistent with empirical data, where 
countries with higher income spend more on health improvement and have on average 
longer life expectancy. 
 
The rest of the paper is arranged as follows. A rough description of the health related data 
in China is given in the next section. In section 3, we present a brief literature review of 
some important empirical studies focusing on the linkage between health expenditure and 
economic growth, and of others touching upon economic growth utilizing exogenous and 
endogenous longevity respectively. We outline the theoretical model of this paper and 
discuss the equilibrium conditions in section 4. In section 5, we further look into how 
health expenditure relates to economic growth by a set of simulations under 
corresponding parameter assumptions. Concluding remarks are made in section 6. 
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2.  Background  
 
Following the amazing tenfold growth of GDP since 1978, total health expenditure in 
China has been experiencing a rapid growth over the past three decades. In 2004, China’s 
total expenditure on health amounted to 747 billion Yuan, while the figure in 1978 being 
11.02 billion Yuan. Total expenditure on health per capita rose from 11.45 Yuan to 
583.90 Yuan during 1978-2004. Total expenditure on health per capita in 2004 was 51 
times as high as the level in 1978. In US terms, China’s total health expenditure was 
917.03 billion dollars in 2004, with that in 1978 being 65.45 billion dollars; total 




This rapid growth of health expenditure is not only observed in absolute terms but also in 
the share of GDP. Table 2-1 shows an upward trend in total health expenditure expressed 
as a share of GDP in China. Over the period from 1978 to 2004, health expenditure in 
China increased from 3.04% to 5.55%, by one percentage point every 10 years in effect. 
In the year 2000, total health expenditure in China was 5.1% of GDP which exceeded the 
WHO’s recommended lower limit of 5%, then in 2002 it accounted for 5.5 % of GDP, 
which was the world average share.  
 
Table 2-1: China’s Total Health Expenditure 1987-2004 
Health expenditure 
   
Health expenditure  
per capita 
   
Year 





Health expenditure  




1978 110.21  65.45  3.04  11.45  6.80 
                                                 
2 All these data are reported in nominal price. 
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1979 126.19  81.15  3.12  12.94  8.32 
1980 143.23  95.61  3.17  14.51  9.69 
1981 160.12  93.91  3.29  16.00  9.38 
1982 177.53  93.81  3.35  17.50  9.23 
1983 207.42  104.99  3.50  20.14  10.19 
1984 242.07  104.03  3.38  23.20  9.97 
1985 279.00  95.01  3.11  26.36  8.98 
1986 315.90  91.49  3.10  29.38  8.51 
1987 379.58  101.98  3.17  34.73  9.33 
1988 488.04  131.12  3.27  43.96  11.81 
1989 615.50  163.48  3.64  54.61  14.50 
1990 747.39  156.25  4.03  65.40  13.67 
1991 893.49  163.09  4.13  77.14  14.49 
1992  1096.86 198.90  4.12  93.61 16.98 
1993 1377.78  239.11  3.98  116.33  20.18 
1994 1761.24  204.35  3.77  146.95  17.05 
1995 2155.13  258.07  3.69  177.93  21.31 
1996 2709.42  325.88  3.99  221.38  26.63 
1997 3196.71  385.62  4.29  258.58  31.19 
1998 3678.72  444.34  4.70  294.86  35.62 
1999 4047.50  488.93  4.93  321.78  38.87 
2000 4586.63  544.05  5.13  361.88  43.71 
2001 5025.93  607.22  5.16  393.80  47.58 
2002 5790.03  686.80  5.42  442.55  53.47 
2003 6584.10  795.47  5.62  509.50  61.61 
2004 7590.29  917.03  5.55  583.90  70.54 
Note: ① Health expenditure in this table is estimated, ② the data in this table are 
calculated at current prices. 
Source: Ministry of Health of the People’s Republic of China, China Health Yearbook 
1987-2004, Abstract of China Health Statistics 1987-2003  http://www.moh.gov.cn 
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Parallel with the rising expenditures on health, there have been major improvements in 
health state in China. According to statistics from Ministry of Health in China (see Table 
2-2), the average life expectancy of people in China has been raised from 35 years in the 
1950s to approximately 72 years in 2004 (65 years in 1975, 67.9 years in1981, 68.5 years 
in 1990 and 71.4 years in 2000), higher than the average for the whole world (67 years) 
and for middle-income countries (69 years). At the same time, the mortality rate of 
Chinese infants declined from as high as 20 percent during some periods in 20
th century 
to 2.5 percent at present. And the mortality rate of children over 5 years old decreased 
from 61.0 per 1000 to 29.9 per 1,000, while the maternal mortality rate decreased from 
94.7 per 100,000 in 1991 to 51.3 per 100,000 in 2004. This improvement is not only 
characterized by better health indicators but also by the improved health infrastructure 
across the country. There are more than 300,000 hospitals and other medical institutions 
in 2005. Compared to 1990, China, in 2000, had 21.2% more beds in its hospitals and 
health centres, and 14.2% more trained health workers. Compared to 1995, in 2001, the 
number of health facilities, including clinics, rocketed by more than 70%. Just as is 
shown in Table 2-3, the general health status in China now equals that in a middle-
income country.  
 
Table 2-2 Selected Life Expectancy in China (Year)  
Year Data  Source  Total  Male  Female
Before 1949     35.0  -  - 
1957 
70 cities, 1 county and 126 townships in 
11 provinces 
57.0 -  - 
1973-1975 
Retrospective Survey on Tumour Death in 
China 
- 63.6  66.3 
1981  The 3rd National Population Census  67.9  66.4  69.3 
1990  The 4th National Population Census  68.6  66.8  70.5 
2000  The 5th National Population Census  71.4  69.6  73.3 
 
Source: Ministry of Health of China, http://www.moh.gov.cn 
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Table 2-3: Selected World Health Indicator (2000) 
   
Health 
expenditure 
 % of GDP 
Life expectancy 







World 5.5  67  81  - 
China 5.1  71  39  56 
Low income 
countries 
4.5 63  121  550 
Middle income 
countries 
5.0 69  38  150 
High income 
countries 
9.7 77  7  10 
 
Source: World Development Report 2002, World Bank 
 
Despite the remarkable gains in key health conditions, expenditures on health may still be 
low and inefficient to meet China’s development needs. By comparison, Table2-4 shows 
the trends in health expenditure of the OECD countries during the same period 1980-
2004, which manifests that China’s total health expenditure as share of GDP is lower 
than that in all these countries. In addition, it is lower than some developing countries 
(e.g. Cuba-7.3%, Brazil-7.6%, 2003) outside this organization. The income elasticity of 
health services spending was very small (1.09) compared with that in OECD countries 
(1.32~1.36). Therefore, the exceedance of demand for health services over the supply 
leads to a heavy medical burden for patients in China now (Peng, 2006) 
 
Table 2-4: Different Performances of Health Care Systems in OECD Countries: 
Total Health Care Expenditure in GDP 
    1985 1990 1995 2000 2001 2002 2003 2004 
Australia  7.2 7.5 8.0 8.8 8.9 9.1 9.2 .. 
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Austria  6.5 7.0 9.7  b  9.4 9.5 9.5 9.6 9.6 
Belgium  7.0 7.2 8.2 8.6 8.7 8.9 10.1b  .. 
Canada  8.2 9.0 9.2 8.9 9.4 9.7 9.9 9.9  e 
Czech Republic  ..  4.7  7.0  6.7  7.0  7.2  7.5 b  7.3 e 
Denmark  8.5 8.3 8.1 8.3 8.6 8.8 8.9  b  8.9  e 
Finland  7.1 7.8 7.4 6.7 6.9 7.2 7.4 7.5 
France  7.9 8.4 9.4 9.2 9.3 10.0b  10.4  10.5e 
Germany  9.0 8.5 10.3  10.4  10.6  10.8  10.9  .. 
Greece  7.4 ²   7.4  9.6  9.9 e  10.4e  10.3e  10.5e  10.0e 
Hungary  ..  7.1 ¹   7.4  7.1  7.3  7.7  8.3 e  8.3 e 
Iceland  7.2 7.9 8.4 9.2 9.3 10.0  10.5  10.2e 
Ireland  7.5 6.1  b  6.7 6.3 6.8 7.2 7.2 7.1 
Italy  7.5  ³    7.7 7.1 7.9 8.0 8.2 8.2 8.4 
Japan  6.7 5.9 6.8  b  7.6 7.8 7.9 8.0  e  .. 
Korea  4.1 4.4 4.2 4.8 5.4 5.3 5.5 5.6 
Luxembourg  5.2 5.4 5.6 5.8 6.4 6.8 7.7  b  8.0  e 
Mexico  ..  4.8 5.6 5.6 6.0 6.2 6.3 6.5 
Netherlands  7.1 7.7 8.1 7.9 8.3 8.9 9.1  e  9.2  e 
New  Zealand  5.1 6.9 7.2 7.7 7.8 8.2 8.0 8.4 
Norway  6.6 7.7 7.9 8.5 8.9 9.9 10.1  9.7 
Poland  ..  4.9 5.6 5.7 6.0 6.6  b  6.5 6.5 
Portugal  6.0  6.2  8.2 b  9.4 b  9.3 e  9.5 e  9.8 e  10.0e 
Slovak Republic  ..  ..  5.8 ²   5.5  5.5  5.6  5.9  .. 
Spain  5.4 6.5 7.4 7.2 7.2 7.3 7.9  b  8.1  e 
Sweden  8.6 8.3 8.1 8.4 8.7 9.1 9.3 9.1  e 
Switzerland  7.8 8.3 9.7  b  10.4  10.9  11.1  11.5  11.6e 
Turkey  2.2 3.6 3.4 6.6 7.5 7.4 7.6 7.7 
United  Kingdom  5.9 6.0 7.0 7.3 7.5 7.7 7.9  b  8.3  d 
United  States  10.1 11.9 13.3 13.3 14.0 14.7 15.2 15.3 
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Notes: ① -1, -2, -3, 1, 2, and 3 indicate that data refer to 1, 2 or 3 years back and forward 
respectively. ② For Germany, data up to 1990 refer to West Germany. ③ "b" means 
there is a break in the series for the given year; "e" means the data is an estimate. 
Source: Organization for Economic Co-operation and Development    
 
These facts attract several Chinese researchers’ attention. Utilizing Granger causality test 
and VAR’s impulse response and variance decompositions, Liu et al(2006) showed that 
the increase of total health expenditure and average health consumption lead to the 
growth of GDP and average disposable income, and then revealed that enhancing 
national health level would promote economic growth. Tan (2005) carried out a 
regression with respect to the health care expenditure and GDP during 1995-2002 using 
OLS and found a rather robust positive correlation between health care spending and 
GDP per capita: one percent increase in health care expenditure will lead to 0.7841 
percent growth in GDP. Wang and Song (2004) found the health care investment is 
closely correlated to the regional economic growth and its contribution to the economic 
growth is most significant in western areas of China. Hu (2004) and Yin (2005) 
suggested that health expenditure doesn’t merely indicate a simple consumption of health 
services, but rather constitutes an important type of investment and hence an impetus for 
economic development in the long term, and thus concluded that we should pay more 
attention to the growth of expenditure on health.  
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3.  Literature Review 
 
Grossman (1972) pointed out that health can be viewed as a durable capital stock that 
produces an output of healthy time. Individuals inherit an initial stock of health that 
depreciated with age and can be increased by investment. In recent years, a growing 
literature has attempted to explain the complex relationship between health investment 
and economic growth through many channels. Health capital can influence the pace of 
economic growth via its effect on many health related factors, including life expectancy, 
mortality rate, labour market participation, and labour productivity, investments in human 
capital, savings, fertility, and demographic structure.  
 
The relationship between health investment, life expectancy and economic growth is a 
newly contested field
3. Worldwide increases in longevity during the last few decades are 
well documented in numerous studies (e.g., World Bank, 1993). The following brief 
review of literatures in this field is organized in three categories: empirical evidence, 
theoretical works correlated to exogenous longevity and those correlated to endogenous 
longevity. 
 
3.1 Empirical Evidence 
 
A common empirical approach to study the effect of health capital on economic growth is 
to focus on a cross-section data of countries and to regress the growth rate of income per 
capita on the initial level of health (typically measured by life expectancy), controlling 
for the initial level of income and for other factors believed to influence steady-state 
income levels. From these cross-country growth regressions, researchers generally find 
that life expectancy, as the most important proxy for the health capital stock, has a 
                                                 
3 The terms survival probability, survival rate, longevity and life expectancy are used interchangeably.  
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significant positive effect on the rate of economic growth. Bloom, Canning and Sevilla 
(2004) constructed a sample consisting of both developing and industrial countries 
observed every 10 years over1960-1990, and found that good health (life expectancy as 
the proxy) has a sizable, positive effect on economic growth. One year improvement in 
the life expectancy contributes to an increase of up to 4 percentage points in the long-run 
growth rate. Shastry and Weil (2003) found that adult mortality explains 19% of the log 
variance of income pre capita, which is almost one-third of the unexplained output 
variation across countries. Jamison, Lau and Wang (2004), using a sample of 53 countries, 
found that improvements in health (measured by the survival rate of males aged between 
15 and 60) account for about 11 percent of growth during the period 1965-90. Zhang and 
Zhang (2005) conducted cross-section analyses using data from 76 countries based on 
their theoretical model, which held life expectancy exerting effect not only on growth but 
also on three growth determinants: education, fertility and saving. Some important 
organizations of developed countries found that high life expectancy exercises weaker 
effects, while in developing countries with low life expectancy and low per capita income 
but high birth rates, efforts on reducing mortality enjoy a good payoff.   
 
This similar strong correlation is also observed in time series data. Fogel (1997) 
estimated that better health and nutrition alone may have contributed about 20-30% of 
British economic growth during 1780-1979. While the results of empirical growth 
equations are generally not completely-robust, Levine and Renelt (1992) and Sala-I-
Martin (1997) found that initial life expectancy is a positive and significant predictor of 
economic growth during 1960-92 in more than 96 percent of the specifications. 
Boucekkine et al. (2003) estimated that a steady decline in adult mortality accounts for 
70% of the growth acceleration during 1700-1820, the early modern period of Europe. 
 
In addition, more studies based on the theoretical framework of Barro and Sala-I-Martin 
(1995) have found evidence of a positive, significant and sizable influence of life 
expectancy (or other health-related indicators) on the subsequent pace of economic 
growth (such as, Barro 1991, 1996, 1997; Barro and Lee 1994; Bhargava et al 2001; 
Easterly and Levine 1997; Gallup and Sachs 2000). All these studies differ substantially 
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in terms of country samples, time frames, control variables, functional forms, data 
definitions and configurations, and estimation techniques. However, parameter estimates 
of the effects of life expectancy on economic growth have been reasonably comparable 
across studies.  
3.2 Exogenous Longevity 
 
As to the theoretical framework, when considering the issue of longevity, theorists 
always assume that an individual’s expected lifetime is independent of his decisions. 
Following Yaari (1965), many researchers have modelled this as a parametric probability 
of surviving from one period to the next. Incorporating this exogenous variable, analyses 
proposed by Ehrlich et al (1999), Zhang et al (2001), Zhang and Zhang (2005) 
demonstrate a positive correlation between life expectancy and economic development.  
 
Ehrlich et al (1999) developed an overlapping-generation model of endogenous growth, 
in which human capital is the engine of growth and generations are linked through 
material and emotional interdependencies within the family. Agents are both consumers 
and producers who invest in their children to achieve both old-age support and emotional 
gratification, and material support from children is determined through self-enforcing 
implicit contracts. Their model produces a theory of the “demographic transition” linking 
longevity, fertility, and economic growth. The family is viewed as a mutual insurance 
mechanism that links over-lapping generations through optimal intra-family transfers, or 
inter-generational trade, as well as through related altruistic sentiments. With a limit in 
lifespan, the parents’ motive of investment in their children is identified to be a 
combination of self-interest and a form of altruism. Thus, despite that population ageing 
may raise the economic growth; an increase in young-age longevity is likely to produce a 
bigger increase in growth rate and reduction in fertility rate.  
 
Zhang et al (2001) examined the effect of longevity on growth in a model with imperfect 
capital markets and public education. Human capital enters production function in 
addition to physical capital. They showed that the decline in mortality affects growth 
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positively or negatively in three ways. Corresponding to empirical evidences, the net 
effect of a decline in mortality is to raise the growth rate in Third World societies; 
however, starting from a low mortality rate in most industrial populations, the net effect 
of a further decline in mortality is to reduce the growth rate. These findings justify the 
concerns about the possible adverse growth effect of rising longevity in developed 
countries, such as the empirical evidences found by Kelley and Schmidt (1995).  
 
In another paper by Zhang and Zhang (2005), a growth model was constructed where 
agents with uncertain survival choose schooling time, life-cycle consumption and the 
number of children. Both leisure and the number of children are incorporated in a 
logarithmic utility function, which captures a trade-off between the cost of children-
bearing and the returns from the offspring. The model shows that rising longevity reduces 
fertility but raises saving, schooling time and the economic growth rate at a diminishing 
rate.  
3.3 Endogenous Longevity 
 
While yielding important insights, all of the above analyses are limited in that agents are 
not allowed to choose life expectancy by themselves. Clearly, this is not true in the real 
economy and it is plausible that life expectancy may change with changes in government 
policies and in other various aspects of social environment. And the endogenous 
longevity is always associated with multiple development regimes.  
 
In the analytical framework by Blackburn and Issa (2002), agents mature safely through 
two periods of life and face an endogenous probability of surviving for a third period. 
They compare different characteristics of exogenous and endogenous life expectancy. An 
exogenous increase in life expectancy leads agents to increase their savings during 
middle-age so as to finance consumption during old-age, which is converted into an 
increase in capital accumulation and growth. When an endogenous life expectancy is 
supported by a constant proportional income tax, the increase in life expectancy feeds 
back on the economic growth process. This produces multiple development regimes such 
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that limiting outcomes depend critically on parameters values and initial conditions. An 
economy that starts up with poor situation may be destined to remain poor (so called 
poverty trap), unless there are major changes in circumstances which allow the threshold 
to be eliminated. 
 
With the same analytical mechanism as Blackburn and Issa (2002), Chakraborty (2004) 
incorporated investment in education in his model. Both health improvement and 
schooling are supported by public expenditures. By assuming a logarithmic utility shape, 
he showed that the dynamic system may have multiple equilibria depending crucially on 
the output share of capital. His results are consistent with those of Blackburn and Issa 
(2002). High-mortality societies do not grow fast since lower longevity discourages 
saving and investment such as education. When human capital drives economic growth, 
countries differing only in health capital do not converge to similar living standards. The 
low-mortality society always invests more intensively in skill at a higher rate and thereby 
augments its health capital at a faster pace. As a result, it consistently enjoys a higher 
growth rate along its saddle-path than the country with higher mortality risks.  
 
Finlay (2005) generalized the environment and broadened the scope of the results in 
Chakraborty (2004). He suggested that economic growth is driven by human capital 
accumulation by way of investment in schooling and this investment is necessary for an 
economy to get out of the poverty trap. However, investment in schooling is concurrent 
to investment in health, as the latter increases life expectancy and thus augments the 
possibility to enjoy the realized returns to the former. Positive investment in health, 
however, is only possible when the individual’s income exceeds a stated threshold. 
Furthermore, investment in schooling will occur when income reaches a second, higher, 
income threshold determined by the level of human capital. To reach these thresholds, it 
is advised that donor countries offer aid in the form of improvements in skill level rather 
than in the baseline level of health, as it is private investment in health that is required to 
encourage investment in education and not exogenously given levels. 
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Instead of assuming that health expenditure is only financed by public sector, 
Bhattacharya and Qiao (2005) used a two-period overlapping-generation model to 
capture the relationship between public and private health expenditures. Their research 
differs from others in that the improvement in longevity is jointly supported by private 
part and public sector, where the survival probability function enables health production 
to be more efficiently stimulated by public health expenditure. They simplified the 
theoretical analysis by concerning the old-age utility only. As in other neoclassical 
growth models, chaotic dynamics are found in their model, and the optimal saving is 
independent of its return which implies that the modelled economy would not produce 
any endogenous fluctuations.  
 
In this paper, we will examine the relationship between health capital, life expectancy 
and economic performance in a very simple two-period overlapping-generation model. 
We allow the individual to investment in their own health capital, which endogenously 
influences their life expectancy and hence exerts an impact on economic growth. In doing 
so, we intend to explore some macro-implications of health capital in the process of 
economic development.  
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4.  The Environment 
 
We now consider a simple two-period overlapping-generation model with discrete time. 
In each time period, a constant number (normalized to unity) of young agents are born. 
Each agent within any generation is identical ex ante. Each generation is considered to 
live for two periods: the “young” age and the “old “age. Agents born in random period t 
live in youth for sure, but survive into the old age only with a probability t π  which is 
determined by their health stock.  
 
In our model, we will follow Grossman’s view (1972) that health can be viewed as a 
durable capital stock and can be increased by investment. Given a health production 
function, agents here are assumed to be able to produce health stock by purposeful health 
investment. Different from conventional conception that only includes spending on 
medical products and services, health expenditure in our model will be broadly defined as 
all spending and activities related to improving the health stock of the agent. Assume that 
the probability for a generation t agent to survive to the second period depends upon her 
health stock,  . The survival probability function therefore can be denoted as t h ( ) tt h π π = , 
which is an increasing function in health stock. It can be thought as a kind of production 
function which makes use of resources to “produce” chances of surviving into the old age. 
Thus, this function can be expected to exhibit the usual properties of a normal production 
function. For analytical simplicity, we assume the following conditions:0( ) 1 π <⋅ < , 
() 0 π′ ⋅> , () 0 π′′ ⋅< , and Inada condition 
0 lim ( )
m h π
→
′ = +∞  and  lim ( ) 0
m h π
→∞
′ = . Finally, the 
health stock of an agent will drop to zero and the agent dies by the end of the second 
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4.1 The Agent’s Problem 
 
When considering the probability of surviving into the second period t π , individuals born 
in periodt maximize their expected lifetime utility over consumption in the first period of 
life , and that in the second period t c 1 t c + . For an individual agent of generation , his 
expected life-time utility can be expressed as: 
t
                                                         1 (, , ) tt t UU c cπ + =    
Here,  , . In order to develop a direct linkage between health expenditure and 
economic growth, we follow several literatures (e.g. Blackburn and Issa 2002) and 
consider the following special case for the above general expected lifetime utility:  
0 U′> 0 U′′ <
                                                 11 (, , ) () ( ) tt t t t t Ucc uc uc π βπ ++ = +  
Agent’s preferences are identical for all generations. The preferences in these two periods 
are given by a strictly increasing and concave utility function , satisfying the Inada 
condition at zero. The utility function from the second-period consumption satisfies an 
additional condition   in case that the agents prefer death to surviving. The 
parameter
() uc
1 () t uc + ≥ 0
β  is utility discount factor, which is not greater than 1 and indicates the 
substitution relationship between different cohorts' utility. And the survival probability is 
always incorporated with β  when demographic impact is considered, such as in the well-
known work by Imrohorolu, Aye; Imrohorolu, Selahattin; Joines, Douglas H (1998). To 
simplify the analysis, we set  1 β =  in our model hence the expected lifetime utility takes 
the form
4: 
                                             1 (, , ) () ( ) tt t t t t Ucc uc uc1 π π + + = +                                          (1) 
All agents in each period are endowed with one unit of labour when young, which is then 
supplied inelastically in the labour market, and 0 when old. By supplying labour, in the 
first period of his life, an agent who is born in period t gets a market wage rate . 
Having earned   when young, the agent only consumes part of this wage in the first 
t w
t w
                                                 
4 Entire insight will goes through if a discount factor smaller than 1 is taken account into the agent’s expected lifetime 
utility. 
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period  , saves some amount to finance the consumption in the next period , and 
invests the rest on the health stock . 
t c t s
t h
                
If an agent survives to the second period, then she has no job any longer but finances her 
consumption entirely by savings. As in other models of uncertain lifetimes, we need to 
deal with the subtle issue of how to treat the retirement savings left by those agents who 
do not survive to old-age. As far as the present analysis is concerned, it makes no 
essential difference as to whether one assumes these savings to be merely wasted (e.g., 
Ehrlich and Lui 1991), or to be distributed among the surviving population of savers 
through actuarially fair annuity markets (e.g. Zhang and Zhang 2001, Yaari 1995 and 
Blanchard 1985). We just follow the latter in assuming a perfect annuities market to 
reallocate the total wealth of those who die before reaching their old age to the remaining 
survivors within the same generation. Quatitatively similar results can be reached as long 
as transfers are made to surviving members of the same cohort. However, if these assets 
are transferred to the offspring of the deceased as accidental bequests, it will result in 
asymptotic growth (Fuster, 1999). To simplify our further analysis, we assume that these 
wealth are equally transferred in a form of lump-sum to the alive:  
                                                       







=                                               (2) 
Therefore, a generation t agent maximizes her expected lifetime utility given in equation 
(2), subject to the following period budget constraints:                     
tt t cwsh t = −−                                                        (3)                                  
11 (1 ) ttt csr t τ ++ = ++                                                  (4)                            
() t ht π π =                                                              (5) 
 
Therefore, taking ,  and  t w t r t τ  as given
5, for the maximization problem of generation t 
agents, the first order conditions with respect to   and   are respectively:  t s t h
                                                   1 () ()( ) ( 1 ) tt tt uc huc r 1 π ++ ′ ′ = +                                          (6) 
                                                 
5 Since the transfer is assumed to be in lump sum, agents view  t τ  as a number that is independent of their individual 
savings decisions because they can’t expect the amount of survival probability.  
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1 () ()( ) tt uc hu c t π + ′ ′ =                                                      (7)  
Actually, Equation (6) is the so called Euler Equation, which means that the marginal rate 
of substitution between current and future consumption equals the expected return on 
savings. In other words, the household chooses saving so as to smooth consumption over 
his life-cycle. And Equation (7) shows the trade-off between the marginal cost and 
marginal benefit of health expenditure. By investing in health stock, the agent decreases 
the current consumption in exchange for an increase in the survival probability in the 
second period. 
4.2 The Firm’s Problem 
 
The firm’s problem in this model is entirely standard. There are many competitive firms 
in this economy, and the number is normalized to unity. As in the standard neoclassical 
model, production is carried out using capital input   and labour input  at time t, 
through constant-return-to-scale technology  that satisfies the usual Inada 
conditions. The aggregate capital stock is assumed to depreciate at the rate
t K t L
( , ) tt FK L
δ . In any 
period t, each firm takes { } , tt wr as given and solves the following problem: 
                                                   ( , ) ( ) tt t t t t FK L w L r K t π δ = −− +                                    (8) 
We assume that capital is depreciated completely in every period, which meansδ =1. If k 
denotes the capital stock per worker, let  () (, 1 ) f kF k ≡  represent the intensive-form 
production function. Perfect competition in the final good market implies that both labour 
and capital are paid according their marginal products respectively, so that prices are 
given in intensive form: 
                                                 1 1( t rf k + 1 ) t + ′ + =                                                              (9) 
                                                 ( ) ( ) tt t wf kk f k t ′ = −                                                      (10) 
We assume that the production technology is represented by a Cobb-Douglas product 
function: 
                                                 ( ) f kA k
α = .                                                                  (11) 
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Here , and 0 A> (0,1) α ∈ . Thus, the firm’s problem leads to the following standard first 
order condition for this product function:  
(1 ) t w t A k
α α =−                                                                  (12) 
                                                
1





                                                               (13) 
Given the balance condition of capital stock 1 (1 ) tt kkδ + = −+ , it yields: 
1 t k + t s =                                                                              (14) 
Finally, the initial capital stock is .  0 0 k >
4.3 General Equilibrium             
 
Combining the first order conditions of agents, we obtain: 
11 () ( ) ()( ) ( 1 ) tt t t t huc huc r 1 π π ++ ′′ + = +                                   (15) 
This gives the condition on how to allocate a marginal dollar, savings versus health 
expenditure. If a marginal dollar is allocated towards savings, the agent gains marginal 
utility from the expected gross return of the dollar. On the other hand, if the same dollar 
is allocated towards health care expenditure, it increases the chance of actually enjoying 
future consumption by ( ) t h π′ . Thus, in equilibrium an agent will allocate the marginal 
dollar towards health expenditure such that the utility gain from health creation just 
equals the utility loss from having less expected second-period income. 
 
Therefore, a competitive equilibrium path of this overlapping-generation economy can be 
represented by a sequence of aggregate capital stocks, individual saving and health 
investment, { , such that they satisfy the first order conditions (6) and (7), in 
addition to equations (2),(3)-(5), (9), (10) and (14). Then the first-period and second-
period consumptions can be expressed as: 
}
t
0 ,, tt t t ksh
+∞
=
                                           ( ) ( ) t tttt cf kk f ks h ′ =− − −                                                  (16) 











=                                                                         (17) 
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Meanwhile, in equilibrium, the sequence of wage rate, the net return of capital and 
individual saving are given by (9), (10) and (14), respectively. 
 
In equilibrium, with the consumption at old age (17) and the net return for next period 
capital (9) and (14), equation (15) gives: 
                                         
() ()





sf s sf s






′′ = ′                        (18) 
The above equation indicates the relationship between health investment and individual 
savings. For a Cobb-Douglas production technology, the total return of capital 
increases as the amount of capital in production increases () kf k ′
6.With this condition, we 
can prove from equation (15) that the amount of saving  and the health investment 
are strictly positively related in equilibrium (see Appendix 1).This means that 
savings/capital and health investment are complements along the equilibrium path despite 
the direct competition for resources. For the agents’ part, there are two motives to save 
more when health investment increases: on the one hand, a higher health investment 
raises the agent’s survival chance and his life expectancy, so that he has more incentive to 
save for the old-age income. On the other hand, as health investment becomes higher, its 




To some extent, the above analysis indicates the possible relationship between health 
investments and economic growth, because health investment will lead to more savings 
and hence growth. In order to examine the role of health investment in the economic 
development more closely, we assume the expected utility function for the agents in 











                                                           (19)  
The utility function form is quite standard, however, we assume a restriction on the 
relative risk aversion coefficient (01 γ < < ) to avoid the agents preferring death to 
                                                 
6 The total return of capital in standard Cobb-Douglas production function is
1 () () kf kk A k f k
α αα
− ′ =⋅ = . Thus, 
 holds because () () 0 fk k fk ′′ ′ +> (( ) ) / ( ) 0 d k fk d k fk α ′ ′ = > . 
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surviving. A value of   1 γ >  will yield a negative utility function in consumption, hence 
1 γ <  is assumed so that consumption has the intuitive effect of positive expected utility 
even at a very low level.
7  
 












                                      (20) 
Here, o π  and (0,1) π ∈ ,  0 1 π π +≤ . In addition, this function consists of two parts which 
are related to two kinds of health capital respectively: the inherent health capital and 
supplementary health investment. This is in line with Finlay (2005), who takes the 
inherent health situation as an exogenously determined value, and health investments 
include public health infrastructures such as a closed sewerage system and access to clean 
water as well as private investments such as private health insurance and physical 
exercises. The first part  0 π  represents the survival probability of an agent if he spends 
nothing on health services, which actually can be regarded as everyone’s inherent health 








 represents supplementary chance of 
survival which increases with the consumption of health services. And π  can be 
interpreted as measuring the state of medical technology: An improvement in π not only 
makes health production more effective, but also raises the maximum amount of life 
extension achieved by health investment. In addition,  (0) π′ = +∞  which means that the 
spending on the health services will be positive in equilibrium and the survival 
probability will go to  0 π π +  as the health investment goes to infinity.  
 
Given the above functions, we obtain an explicit form of equation (15): 
                                                 
7 In this model of uncertainty, expected utility is interpreted as cardinal utility and not ordinal utility, hence the value of 
utility matters. Moreover, in this OLG model the implicit expected utility of death is zero, so when expected utility of 
consumption is negative then the individual will always prefer dying to living no matter how high consumption is. 
Therefore, if 1 γ > ,  a strictly positive investment in health will never occur. (Finlay, 2006)  
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                                        (21) 
Equation (9), (14) and (17), (21) give:   
                                       
2 ()













                                                       (22) 
This equation is the explicit form of equation (18), which indicates the complementary 
relationship between health investment and saving in equilibrium. Given ( ) t h π is 
increasing and concave and 1 γ < ,   is an increasing function with respect to health 
investment. This confirms the positive relationship between savings and health 
investment.  
( ) t sh
 
We further investigate how health investment is linked to economic growth with this 
given explicit form. With the utility function given in (19), inserting equation (10), (16) 
and (17) into the first condition (6), we obtain: 



















                                 (23) 
The parameter α  in production function represents the share of capital income in total 
output. Several empirical works have indicated that the value of α ranges from 0.25 to 
0.4 (e.g. Mankiw, Romer, and Weil 1992)
8, so that  1/2 α <  is a reasonable restriction 
forα . Under this condition, we can prove that health investment is increasing with 
respect to capital labour ratio  (see Appendix 2). Given the positive relationship 
between health investment and individual savings, the increase in capital   will lead to 
the growth of   and , which implies an increase in
t k
t k
t h t s 1 t k + . It means, an increase in the 
capital stock allows the economy to invest more in health, which leads to more saving for 
future capital stock. Finally, these dynamic evolutions of variables make economy 
converge to the steady state. In this model, the equilibrium dynamics are determined by 
the initial per-capita capital stock , (14), (22) and (23). The dynamics of this economy  0 k
                                                 
8 In our model, the agents live two periods (always assumed 30 years or longer per period).The values are reported in 
these literatures without our special assumption that capital is depreciated completely in every period. However, this 
value range is still reasonable, because we can expect the complete depreciation of capital after 3o years if the physical 
capital is normally depreciated. 
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converge to a unique steady state (See Appendix 3) characterized by   
and . 
tt skks == =
t hh =
 
Income increases with the accumulation of capital because of the positive relationship 
indicated in equation (10). This implies that health investment is indeed a normal good, 
which is in line with Grossman’s view mentioned in the introduction part. Thus, 
economic growth will raise the accumulation of health capital; richer countries spend 
more on health improvement and have a higher average life expectancy.  
4.4 The Economy without Health Investment 
 
We investigate the role of health expenditure in economic growth in our model; however, 
health investment is typically omitted in most of the economic growth models. We can 
get better understanding about the impact of such omission in conventional models, as 
well as the effect of health care on growth, by comparing our model with a benchmark 
model. This benchmark model is identical with our model except that the former doesn’t 
include the health care sector, which means that health investment is zero ( ) and 
survival probability 
0 t h =
t π is equal to 0 π .  
 
In this benchmark economy, the firm’s problem is the same as that in our model; however, 
the agent faces a new optimal problem: 
                                                  01 0 0 (, , ) () ( ) tt t t Ucc u c u c 1 π π + + = +                                      (24)   
Subject to: 
  tt cws t = −                                                                        (25)                             









=  is the wealth transferred to the alive when 0 t π π = . The 
maximization problem of generation t agents gives the following first order condition 
with respect to :  t s
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                                                  01 () ( ) ( 1 ) tt uc uc r 1 t π + + ′′ = +                                             (27) 
 
Following the similar steps in our model with health investment, we get the competitive 
equilibrium path of this benchmark economy. It is characterized by a sequence of 
that satisfies the first order conditions (27), and equations (24), (25), (26), (9), 
(10) and (14). Now, the first-period and second-period consumptions can be expressed as: 
{} 0 , tt t sk
+∞
=
                                                     ( ) ( ) tt t t cf kk f ks t ′ = −−                                              (28) 









=                                                             (29) 
Meanwhile, in equilibrium, the sequence of wage rate, the net return of capital and 
individual saving are given by (9), (10) and (14), respectively. 
 
Therefore, with the utility function given in equation (19), the steady state of this 
benchmark economy can be expressed as: 



















                                  (30) 
The equilibrium dynamics are determined by the initial per-capita capital stock , (14), 
and (30). This benchmark economy also has a unique steady state (See Appendix 3).  
0 k
 
With reasonable parameters ( 0 0.2, 0.6, 0.5, 0.4 π πγα = === , discussed in detail in the 
next section), we simulate the transition paths of capital-labor ratio for the cases with and 
without health investment (see Figure 4-1). Considering the two economies that differ 
only in their health capitals, we use Figure 4-1 to describe the steady states in these two 
economies when the output share of capital is less than 1/2. Starting with the same level 
of initial capital stock, the economy with health investment will enjoy higher survival rate.  
The dynamic behavior of the society with better health status is described by the upper 
line, whereas the lower line applies to the high-mortality economy omitting health 
investment.These two curves follow from equations (22)and (23) with endogenous 
survival rate and from equation (30) with exogenous survival rate. Along the transition 
path, the capital-labor ratio in the economy with health investment is higher than that in 
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the benchmark economy without health investment. We calculated the saving level in the 
two cases numerically for a given  capital stock, saving in former case is higher than that 
in the latter case. In the economy with better health, agents expect themselves to live into 
the second period with higher probability and to enjoy a longer life expectancy, and thus 
save more for the future life. This length-of-life effect leads to higher capital stock which 
in turn brings more health investment. In the counterpart economy, higher mortality rate 
will make individuals effectively impatient, which depressing saving, capital 
accumulation and health investment further. From Figure 4-1, obviously, the upper one 
converges to a higher steady-state capital-labor ratio, because expenditure on health leads 
to faster capital accumulation. Despite that health investment diverts resource from 
productive use, it extends life expectancy which in turn leads to higher capital 
accumulation and hence economic growth.     
 
Figure 4-1: Steady states with and without health investment 













k(t+1) without health investment
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5.  Simulation Analysis 
 
In this section, using the calibrated parameters of China, we run MATLAB 7.0 to 
simulate these two economies and to compare their steady states. Furthermore, we carry 




A  0 π   π   α   γ  
10  0.2 0.6 0.4 0.5 
 
Li et al. (1993) estimated the capital income share in China to be 0.464 for the reform 
period. In our base simulation, the value of labour share is taken from the study of Wang 
(2003), in which labour income is taken to be the average labour remuneration across 
China’s 28 provinces and the share calculated thereby remains fairly steady at this level 
over the entire reform period of 1978-99. Many literatures (e.g. Mankiw 1981, Mankiw et 
al 1985, and Hansen and Singleton 1983) show that the inter-temporal substitution rate 
(the inverse of the relative risk aversion coefficientγ ) ranges from 1 to 10. In their paper 
on China’s optimal saving ratio, Yuan and Song (2000) took this value to be 3, 5 and 7. 
We selectγ = 0.5 in our base case simulation. Other values will be used in sensitivity 
analysis.  
 
We assume survival probability depends on both inherent health capital and 
supplementary health investment. The inherent survival probability can be assumed to be 
the probability of surviving to age 65 (retirement age) before People’s Republic of China 
was founded. In fact, during that period, there was a lack of any formal health investment 
since people were even short of adequate food for survival due to warfare, and life 
expectancy at birth was only 35 (see Table 2-2). According to the World Bank 
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Development Indicators 2001, the survival probability in some poorest African countries 
ranges from 0.2 to 0.4 (for instance, it is 0.22 in Sierra Leone), and their life expectancy 
at birth ranges from 35 to 40 years. Since we lack related data of China in that period, we 
could reasonably choose  0 0.2 π =  as an approximation in the base case, and other values 
will also be tested. In addition, given that survival probability to age 65 is 0.73 in China, 
with the same argument,  0.6 π = seems to be a reasonable starting point which implies 
that the medical technology allows a survival probability to the retirement age up to 0.8. 
Therefore, we choose the model without health investment as the benchmark 
with 0 0.2 π = , which is parallel to the case before the founding of People’s Republic of 
China. 
 
Our simulation results concentrate mainly on seven variables. The medical technology 
efficiency parameter π is used as a proxy to study whether incorporating endogenous 
health investment leads to higher steady state income per capita and welfare, compared 
with the benchmark model where the role of health investment in reducing mortality is 
absent.  
5.2 Health Investment and Growth 
 
Simulation results for health investment  are summarized in Table 5-2. The second, 
third and fourth columns simply show the steady state values of health investment and its 
proportion to income and GDP, expressed by  ,  and   respectively, followed 
by the survival rate 
h
h / hw /( ) hf k
() h π  and capital stock   in the fifth and sixth columns. Since the 
young agents are the only workers in the economy, GDP per worker is simply measured 
by 
k
() f k  in the seventh column. GDP per capita is then measured as  () f k divided by the 
total population including the old agents, 1( h) π + , in the eighth column. In the last 
column, welfare level is measured by the stationary lifetime utility of agents alive in the 
steady state 12 ( ) ()( ) uc huc π + , where  and  are consumption levels of an agent at 
young age and old age in the steady state.  
1 c 2 c
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One immediate impression from Table 5-2 is that the steady state values of capital stock, 
GDP per worker, GDP per capita and welfare are obviously higher in our model with 
endogenous health investment than in the benchmark. Even though a higher steady state 
capital stock  is associated with a greater health investment , we should notice that 
there is no direct causality between  and GDP per capita as well as welfare in our 
theoretical model. However, this conclusion is robust with respect to the state of medical 
technology and a wide range of other parameter values (see sensitivity analysis). These 
results provide a convincing support to the hypothesis that health expenditures promote 
economic growth and welfare. In other words, it suggests that the conventional empirical 
studies about economic growth of China that omit health investment as an explicit choice 
variable tend to either underestimate growth or overestimate the roles of other factors in 
production. Quantitatively, Table 5-2 shows that the effects of incorporating health 
investment into the benchmark model are economically significant. We can see that, with 
specific level of medical technology
k h
h
π , investment in health stock could potentially 
improve both the steady state GDP per capita and welfare by as much as around 100% 
over the benchmark levels. 
 
Furthermore, Table 5-2 exhibits a positive association between health expenditure to 
GDP ratio and medical technology. The observed cross-country pattern in health 
expenditure in Table 2-3 might be partially explained by different availability levels of 
medical technology among different country groups. Table 2-3 reveals that the difference 
in health expenditure to GDP ratio between low and middle income countries is much 
smaller (4.5% and 5.0% respectively) than that between middle and high income 
countries (9.7%). Matching our simulated health expenditure shares in Table 5-2 with the 
data in Table 2-3 requires a π value of roughly 0.16, 0.18, and 0.8 for low income, 
middle income and high income countries respectively. This implication seems to fit 
quite well with the observed fact that, while some rough medical technology is basically 
available all over the world (such as China), more advanced medical innovation are 
mostly implemented in high income countries. 
 




We also see the effects of medical technology in Table 5-2. The enhancement of medical 
technology, i.e. the increase inπ , leads to increases in all variables in Table 5-2. In a 
research report, using a stochastic, multi-period overlapping-generation model as the 
analytical vehicle, Suen (2005) proposed that improvements in medical treatment and 
rising incomes can explain all of the increase in medical spending and more than 60% of 
the increase in life expectancy at age 25 during the second half of the twentieth century. 
Consequently, the economic impact of improving medical technology in our model is 
quite significant. For instance, raising 
                                                
π from 0.1 to 0.8 can bring about an increase of 
86% in GDP per capita and of 76% in welfare. Particularly, in Table 5-2, the π  values of 
0.1 and 0.2 correspond to the health expenditure to GDP ratios of China during the early 
period of reform and the recent period (see Table 2-1)
9. We see that the simulated steady 
state GDP per capita and welfare are improved by as much as 19% and 13% respectively 
in the wake of a small-extent enhancement in medical technology. Naturally, the power 
of continuous improvement in medical technology declines due to the diminishing 
marginal returns in both goods production and health production. We find that, 
an increase of π from 0.1 to 0.2 leads to about 33% rise in survival probability and 19% 
rise in GDP per capita (as is mentioned above in China case), while an increase of 
π from 0.7 to 0.8 only leads to about 12% rise in survival probability and 3.0% rise in 
GDP per capita. Intuitively, medical advancement entails greater incentives to spend on 
health improvement, but the survival probability function shares the common features of 
other production functions, namely, diminishing marginal returns with respect to factors.  
 
9 Note that the morale of comparing steady state GDP per capita between these two periods is to emphasize the role of 
improvement in medical technology (in reality, the GDP per capita is increased by roughly 6 times from 1980 
according to China National Statistical Bureau). This is the same with other comparisons among low income, middle 
income and high income country groups.  
 
30
π   Health 
expenditure 
Health Expenditure 
% of Wage income 
Health expenditure 











Benchmark  0  0  0  0.20  0.24 5.63 4.69 4.88 
0.1  0.21  5.14  3.08  0.24  0.37 6.71 5.39 5.34 
0.2  0.47  9.31  5.59  0.32  0.66 8.47 6.42 6.06 
0.3 0.71  11.50  6.90  0.40  1.09  10.34  7.37  6.78 
0.4 0.92  12.66  7.59  0.49  1.63  12.16  8.18  7.44 
0.5 1.11  13.26  7.95  0.57  2.28  13.90  8.83  8.03 
0.6 1.26  13.54  8.12  0.66  3.01  15.53  9.35  8.55 
0.7 1.39  13.64  8.18  0.75  3.79  17.04  9.74  9.01 
0.8 1.50  13.62  8.20  0.84  4.60  18.42  10.03  9.41 
 
Health expenditure — , Health expenditure % of Wage income — , Health expenditure % of GDP — ) , Survival rate — h / hw /( hf k
() h π , Capital stock — , GDP per worker — k () f k , GDP per capita — () / ( 1 () ) f kh π + , Welfare — 12 ( ) ()( ) uc huc π +  
Note: the reported variables in the table are defined as follows
10 
Parameters:  0 0.2, 0.4, 0.5, 10 A π αγ ====  
Table 5-2: Lump sum health investment 
                                                 
10 These definitions are the same in all tables in this section.    31
In addition, the third column in table 5-2 shows health expenditure to income ratio. This 
ratio can be thought as a kind of health tax levied by the government upon income, such 
as the income tax rate in national health insurance program in many countries. According 
to the data from WHO, in several high-income countries, such as Germany and USA, 
national health insurance program covers more than 2/3 of the population with a tax rate 
of 11%-14%. This is consistent with the simulation results in the third column, if we 
assume that national health sector provides most of the medical products and services and 
disregard the welfare effect of national health programs (for example, some forms of 
medical subsidies). When we come to the case of China, its health expenditure to GDP 
ratio (average value in recent 5 years is around 5.5%) and correspondingπ value (about 
0.18) are ranked in the middle income country group. The simulated health expenditure 
to income ratio of 9.3% is higher than 8%, the level that is jointly supplied by individuals 
and employers in current Urban Basic Medical Insurance. However, the current coverage 
of this social health insurance program is only about 10% (2006), and the private health 
expenditure accounts for as much as half of the total health expenditure. Some 
researchers, such as Tan (2005) and Wang (2004), suggest that the public health 
expenditure should play a more important role in national health improvement. Thus, the 
current tax rate is apparently underestimated if Urban Basic Medical Insurance tends to 
cover more people. Since we lack enough data for the worldwide national health 
programs and regarding that the operation of public health system is not the focus of this 
paper, we will not discuss this topic further.  
 
5.3 Sensitivity test  
 
We also carry out sensitivity test of the simulation results discussed above. Varying 
exogenous parameters within reasonably wide ranges of values yields similar results that 
differ only quantitatively. Therefore, we are reasonably convinced that our core analysis 
and results on the relationship between health investment and economic growth in the 
present paper are quite robust in the qualitative sense. Sensitivity test results are reported 
in Table 5-3. The sensitivity results with respect to  0 π may seem particularly interesting. 
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Incorporating endogenous health investment in our model, steady state values of GDP per 
worker, GDP per capita and welfare do not vary drastically as the state of innate health 
stock ranges from 0.1 to 0.3. Intuitively, supplementary health investments optimally 
evade the inherent health risk and keep the economic growth and welfare at a relative 
high level. On the other hand, without necessary supplementary health investment, 
innately low heath state (for example, in the present poorest countries) may probably drag 
the society into a poverty trap.  
 
Note that while our model is capable of closely matching the empirical data on health 
expenditure to GDP ratio in Table 2-1and Table 2-2 under reasonable parameter values, 
the simulated survival rates in Table 5-2 are systematically lower than those in the former 
two tables. One plausible reason is that we only consider health expenditures of medical 
products and services but neglect other health-related factors such as personal life style, 
living environment, and international medical aids. In fact, various food and health aid 
programs provided by international organizations to poor countries have significant 
impact on the local mortality rate. It is not surprising to see that the underestimation of 
the survival rate in our simulation is more substantial in those low-income countries. 
 
Table 5-3: Sensitivity test 
1) Alternative value ofα  
Parameters:  0 0.2, 0.6, 0.5, 10 A π πγ ====   


















0.30 0.2  6.73 5.61 5.49 0.65  13.08  7.93 7.92 
0.35 0.2  6.21 5.17 5.21 0.66  14.20  8.58 8.22 
0.40 0.2  5.63 4.69 4.88 0.66  15.53  9.35 8.55 
0.45 0.2  4.98 4.15 4.52 0.67  17.09  10.26  8.90 
0.50 0.2  4.27 3.56 4.10 0.67  18.87  11.30  9.26 
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2) Alternative value ofγ  
Parameters:  0 0.2, 0.6, 0.4, 10 A π πα ====   


















0.1 0.2  7.88  6.57  6.68  0.65 17.97  10.90  11.31 
0.3 0.2  6.64  5.53  5.27  0.65 16.59  10.04  9.30 
0.5 0.2  5.63  4.69  4.88  0.66 15.53  9.35  8.55 
0.7 0.2  4.78  3.98  5.81  0.68 14.58  8.68  9.59 
0.9 0.2  4.07  3.39  13.35  0.71 12.80  7.47  19.99 
 
3) Alternative value of A 
Parameters:  0 0.2, 0.6, 0.5, 0.4 π πγα ====   


















5 0.2  1.77  1.48  2.74  0.56  4.17  2.68  4.30 
10 0.2 5.63  4.69  4.88  0.66  15.53  9.35  8.55 
15 0.2 11.05  9.21  6.85  0.70  32.38  19.02  12.52 
20 0.2 17.84  14.87  8.70  0.72  53.92  31.29  16.29 
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4) Alternative value of  0 π  
Parameters:  10, 0.6, 0.5, 0.4 A π γα == = =  


















0.10  0.10 2.86  2.60  3.26 0.56 13.49  8.65  7.83 
0.15  0.15 4.26  3.70  4.13 0.61 14.54  9.02  8.21 
0.20  0.20 5.63  4.69  4.88 0.66 15.53  9.35  8.55 
0.25  0.25 6.96  5.57  5.55 0.71 16.48  9.63  8.86 
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6.  Concluding Remarks 
 
Widespread empirical evidence and theoretical works, at both individual and aggregate 
levels, reveal a strong correlation between economic growth and health status or life 
expectancy. In this paper, we presented an overlapping-generation model with production 
(Diamond 1965) modified to include endogenous longevity risk, and examined the inter-
dependence between health investment and economic development in a general 
equilibrium framework. We showed in our model that optimal health investment and 
savings are complements in that they rise and fall together along a development path.  
 
Compared to the benchmark model with a constant exogenous survival probability, our 
simulation showed that, the optimal health expenditure is growth-promoting as well as 
welfare-improving. The impact of health investment on economic growth is particularly 
meaningful because it exists in the context where health investment brings a higher life 
expectancy and hence entails higher dependency ratio induced by potential population 
ageing. Therefore, in the light that China is experiencing a rapid population ageing 
process, it is suggestible to pay more attention to the accumulation of health capital by 
increasing health expenditure especially the health investment from the public sector. 
Furthermore, our findings are consistent with several stylized facts observed in the data, 
where countries with higher income spend more on health improvement and have on 
average higher life expectancy.  
 
However, there are two ways to get a better gauge of the importance of health. One 
approach is to use cross-country evidence and more sophisticated econometric methods, 
as is used in McGrattan and Schmitz’s (1998) analysis of cross-country growth or 
Kalemli-Ozcan et al.’s (2000) study of the effects of (exogenous) mortality decline. The 
other way is, to better quantify the contribution of health investment in China, we need a 
more complicated overlapping-generation model to project the economic growth with 
adequate time series data as Suen (2005) did. As a preliminary pass to formally analyze 
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the role of health capital, we utilized a very simple neoclassical model in the present 
paper. We disregarded several other health-related factors that could affect economic 
growth significantly, such as labour efficiency, working years and the impact of parents’ 
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Appendix 1: Individual Saving and Health 
Investment  
Ignoring the time subscript, equation (15) gives:  
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As is shown in the footnote 4, we have  () () 0 fk k fk ′ ′′ + >  for a Cobb-Douglas product 
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Appendix 2: Health Investment and Capital Stock  
 
We can’t get the direct relationship between capital and health investment using normal 
differentiation, however, we can solve it by way of reduction to absurdity: 
Inserting (22) into (23), it yields: 
[]
11 1




hs hf s h
fk kf k s h
γ γγ
γ π
+ −− ′ =
′ −− −  
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) 1 γ −
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γγ α απ
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Suppose that   rises and  (thus ) falls, on the left hand side, the denominator will 
increase thus LHS will decrease. On the right hand side, with
t k t h t s
1/2 α <  as is shown in 
many empirical works (e.g. Mankiw, Romer and Weil 1992) and0,1 γ α < < , the 
numerator decreases but the denominator increases, RHS will increase. It is a 
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Appendix 3: Solutions to Steady State Capital 
 
Parameter: 0,1 γ α <<  
 
1. Steady state without health investment 
Because the steady state is characterized by  tt skks = == and t hh = , in addition to 
() f kA k
α = , equation (30) can be rewritten as: 
11 1
0 [() () ] [ ( 1 ) ] ( ) f kk f kk A kk A k k
γ αγ γ α γ απ α
−− + ′ −− = − − =
γ − −  
1


















Define the LHS of the above equation as , and denote the RHS as C(>0).  () Jk
Since
(1 ) ( 1) 11
11
1 11
() [( 1 ) ] [( 1 ) ]
() ()










− =− − = − − = , we have: 
0 lim ( )
k Jk
→ =∞,  and is monotonically decreasing in . We can confirm 
there is a unique  for . 
lim ( ) 0
k Jk
→∞ = () Jk k
* k () Jk C =
When the utility takes a log form (a special case of CRRA utility), it is convenient to 
prove that there exists only one non-trivial steady state. We do not prove it for the case of 
our utility shape, but simulate the law of the motion for 1 t k + in the following figure with 
the parameters used in our base case (see simulation part). Obviously, the intersection 
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Figure 1: Dynamics without health investment 


















2. Steady state with health investment 
Because the steady state is characterized by  tt skks = == and t hh = , in addition to 
() f kA k
α = , equation (23) can be rewritten as: 
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Since  is bounded in and positive, we can confirm the existence of solutions 
for . Unfortunately, we are not able to prove the monotonies of . 
However, with a set of parameters we use in the base case simulation, the following 
figure shows that  and intersect only once within a large-enough interval. 
And the sensitivity test shows that simulation results are robust in a relatively small 
interval. See also the simulated transition path of
() Jh h
(() ) () Pkh Jh = (() ) Pkh
(() ) Pkh () Jh
1 t k + and in Figure 3.  t h
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Figure 3: Dynamics with health investment 
5















   